RNA-seq of K562 cells treated with EPZ-6438 or GSK126. EZH2 inhibitor treatment of CML cell lines (K562, KCL22, AR230-s)
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJEB51336
下载链接
链接失效反馈官方服务：
资源简介：
The chronic myeloid leukemia cell lines K562, KCL22, and AR230-s were treated with 2uM of the EZH2 inhibitors EPZ-6438 (Tazemetostat, all cell lines) or GSK126 (K562 only) for 72 hours. RNA-seq was conducted to analyze gene expression and splicing changes. The experiment was performed in three biological replicates.
创建时间：
2024-03-30
